论文部分内容阅读
早在70年代初,世界卫生组织和洛氏基金会大力支持了避孕疫苗的研究,hCG是优先发展和重点支持的第一个生育调节疫苗。经过二十多年的深入研究,hCG疫苗取得了突破性进展,印度国立免疫研究所的Talwar教授成功地研制了世界上第一个避孕疫苗,这种疫苗可持续避孕一年,没有付作用,它的成功成为避孕疫苗研究的重要里程碑。
As early as the early 1970s, WHO and the Rockwell Foundation strongly supported the study of contraceptive vaccines and hCG was the first fertility-adjusted vaccine to be given priority support and priority. After more than two decades of in-depth research, breakthroughs have been made in the hCG vaccine. Professor Talwar of the National Institute of Immunization of India successfully developed the world’s first contraceptive vaccine which can be contracted for one year without pay. Its success has become an important milestone in contraception vaccine research.